While tumors from mice receiving combined treatment of tumor vaccination and SUREK tended (even though it was not significant) to express less GD2 compared to mice not receiving SUREK, GD2 expression was completely absent in 3 of 4 mice (75%) also receiving PD-1-blocking therapy (Figure 4D). Here, PDCD1 is linked to neoplasm.